Process for preparing aminopyrimidine compounds

By employing a guanidine reagent and halogenated alcohol solvent system, the method enhances the yield of aminopyrimidine compounds, addressing the scalability issues in existing synthetic processes and facilitating their commercial production.

JP7581244B2Active Publication Date: 2024-11-12ARCUS BIOSCIENCES INC
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
JP2021568910
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-06-06
Filing Date
2020-06-05
Publication Date
2024-11-12
Estimated Expiration
2040-06-05

AI Technical Summary

Technical Problem

The existing synthetic processes for preparing aminopyrimidine compounds are difficult to scale up, hindering their commercial availability due to low yields and inefficiencies.

Method used

A method involving the use of a guanidine reagent and a solvent system containing a halogenated alcohol to form a compound of formula (B), followed by substituting the hydroxyl group to produce a compound of formula (I), which includes steps to enhance yield and efficiency.

Benefits of technology

The method significantly improves the yield of aminopyrimidine compounds, making them more suitable for large-scale production and commercial availability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007581244000001
    Figure 0007581244000001
  • Figure 0007581244000002
    Figure 0007581244000002
  • Figure 0007581244000003
    Figure 0007581244000003
Patent Text Reader

Abstract

Provided herein are improved methods for preparing aminopyrimidine compounds of formula (I). The disclosed method advantageously proceeds via a β-diketoester intermediate of formula (A), avoiding direct coupling of the pyrimidine and phenyl moieties. The disclosed method significantly increases the yield of the target compound and simplifies the synthetic route.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority under 35 U.S.C. § 119 to U.S. Provisional Application No. 62 / 858,050, filed June 6, 2019, which is incorporated by reference in its entirety for all purposes.

[0002] STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT N / A

[0003] Reference for sequence list etc. N / A [Background technology]

[0004] Adenosine is a purine nucleoside compound that contains a complex of adenine and a ribose sugar molecule (ribofuranose). Adenosine occurs naturally in mammals and plays an important role in multiple biochemical processes, including energy transfer (as adenosine triphosphate and adenosine monophosphate) and signal transduction (as cyclic adenosine monophosphate). Adenosine also functions in processes related to vasodilation, including cardiac vasodilation, and also functions as a neuromodulator (e.g., thought to be involved in promoting sleep). In addition to its involvement in these biochemical processes, adenosine is used as a therapeutic antiarrhythmic drug, for example, to treat supraventricular tachycardia. As described in detail herein, tumors evade the host response by inhibiting immune function and promoting resistance, and adenosine has been shown to play an important role in mediating tumor evasion of the immune system. A is expressed in various immune cell subsets and endothelial cells. 2A RS and A 2BAdenosine signaling through the RS has been shown to have an important role in protecting tissues during inflammatory responses, such that under certain conditions adenosine protects tumors from immune destruction (see, e.g., Fishman, P, et al. (2009) Handb Exp Pharmacol 193:399-441).

[0005] Adenosine receptors are a class of purinergic G protein-coupled receptors that have adenosine as their endogenous ligand. The four types of adenosine receptors in humans are A1, A2, A3, A4, A5, A6, A7, A8, A9, A10, A11, A12, A13, A14, A15, A16, A17, A18, A19 ...20, A21, A22, A23, A24, A25, A26, A27, A28, A29, A30, A31, A32, A33, A34, A35, A36, A37, A38, A39, A 2A , A 2B Modulation of A1 has been proposed for the management and treatment of, for example, neurological disorders, asthma, and heart and kidney failure. 2A Antagonists have been proposed, for example, for the management and treatment of Parkinson's disease. 2B Modulation of A3 has been proposed for the management and treatment of chronic lung diseases, including, for example, asthma. Modulation of A3 has been proposed for the management and treatment of, for example, asthma and chronic obstructive pulmonary disease, glaucoma, cancer, and stroke.

[0006] Historically, adenosine receptor modulators have been nonselective. However, recent studies have demonstrated that adenosine A 2A Receptor (A 2A R) or adenosine A 2B Receptor (A 2B Useful adenosine modulators capable of specifically targeting adenosine receptor agonists (AARs) have been identified. Such studies include compounds containing an aminopyrimidine moiety, as described in WO2018 / 136700.

[0007] Despite these advances, the synthetic processes described for preparing the compounds of WO2018 / 136700 involve chemical transformations with lower yields that impede large-scale production and impede commercial availability of the compounds.

[0008] Thus, there is a need in the art to provide improved methods for preparing aminopyrimidine compounds. The present disclosure addresses this need and provides related advantages as well. Summary of the Invention

[0009] In some embodiments, provided herein is a compound represented by formula (I): [ka] (In the formula, R 1a , R 1b , R 2a , R 2b , R 3 and X is as described herein. A method for preparing a) A compound of formula (A) [ka] (In the formula, R 4 is selected from the group consisting of C1-C8 alkyl and C3-C8 cycloalkyl, each of which is optionally substituted with 1-6 members independently selected from the group consisting of F and Cl. with a guanidine reagent and a solvent system containing at least one halogenated alcohol to produce a compound of formula (B) [ka] to obtain; and b) substituting the hydroxyl group of formula (B) to form a compound of formula (I); A method of preparation is disclosed, comprising:

[0010] In some embodiments, the compound of formula (I) is a compound of formula (Ia) [ka] It is.

[0011] In some embodiments, provided herein is a compound of formula (II): [ka] (In the formula, R 1a , R 1b , R 2a , R 2b , R 3 are as described herein) A method for preparing a') preparing a compound of formula (I) according to the methods described herein; b') reacting the compound of formula (I) with a compound of formula (C) [ka] Converting into; and c') reacting the compound of formula (C) with an azide compound of formula (D) [ka] to form a compound of formula (II); A method of preparation is disclosed comprising:

[0012] In some embodiments, the methods described herein comprise the step of: [ka] It is useful for the manufacture of [Brief description of the drawings]

[0013] N / A DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0014] 1. Overview The present disclosure provides an improved method for preparing an aminopyrimidine compound of formula (I). In particular, the method described herein uses a compound of formula (A) having a guanidine and a β-diketoester to provide a compound of formula (B). This conversion advantageously improves the yield for the preparation of the compound of formula (B). Subsequent conversion of the alcohol of formula (B) can be used to prepare the compound of formula (I).

[0015] The methods described herein are particularly useful in the preparation of 3-[2-amino-6-(1-{[6-(2-hydroxypropan-2-yl)pyridin-2-yl]methyl}-1H-1,2,3-triazol-4-yl)pyrimidin-4-yl]-2-methylbenzonitrile, although it is understood that the synthetic methods disclosed herein can be used to improve the efficiency and synthetic yield of numerous compounds.

[0016] II. Definition The term "contacting" as used herein refers to the process of contacting at least two different species so that they can react. However, it should be understood that the resulting reaction product may be generated directly from the reaction between the added reagents or from an intermediate derived from one or more added reagents that may be generated in the reaction mixture.

[0017] The term "alkyl," as used herein, by itself or as part of another substituent, means, unless otherwise stated, a straight or branched chain hydrocarbon radical. Alkyl substituents, as well as other hydrocarbon substituents, may include a numbered designation indicating the number of carbon atoms in the substituent (i.e., C1-C8 means 1-8 carbons), although such designation may be omitted. Unless otherwise stated, alkyl groups of the present invention contain 1-12 carbon atoms. For example, alkyl groups can contain 1-2, 1-3, 1-4, 1-5, 1-6, 1-7, 1-8, 1-9, 1-10, 1-11, 1-12, 2-3, 2-4, 2-5, 2-6, 3-4, 3-5, 3-6, 4-5, 4-6, or 5-6 carbon atoms. Examples of alkyl groups include methyl, ethyl, n-propyl, isopropyl, n-butyl, t-butyl, isobutyl, sec-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, and the like.

[0018] "Alkoxy" refers to an alkyl group having an oxygen atom connecting the alkyl group to the point of attachment: alkyl-O-. In reference to the alkyl group, the alkoxy group is 1~6 Alkoxy groups can have any suitable number of carbon atoms, such as methoxy, ethoxy, propoxy, iso-propoxy, butoxy, 2-butoxy, iso-butoxy, sec-butoxy, tert-butoxy, pentoxy, hexoxy, and the like. Alkoxy groups can be further substituted with various substituents as described herein. Alkoxy groups can be substituted or unsubstituted.

[0019] "Halogen" or "halo" refers to fluorine, chlorine, bromine, and iodine.

[0020] The term "protecting group" as used herein refers to a moiety formed to render a functional moiety unreactive. The protecting group can be removed to restore the functional moiety to its original state. A variety of protecting groups and protecting reagents, including nitrogen protecting groups, are well known to those skilled in the art and include compounds described in Protective Groups in Organic Synthesis, 4th edition, TW Greene and PG M Huts, John Wiley & Sons, New York, 2006, which is incorporated herein by reference in its entirety.

[0021] The term "basic" as used herein is an adjective that refers to a chemical that is a base. A basic additive refers to an additive that is a base. Basic reaction conditions refer to reaction conditions that include a pH value greater than 7.

[0022] III. EMBODIMENTS OF THE DISCLOSURE A. Preparation of Compounds of Formula (I) The inventors of the present disclosure have discovered that the combination of a compound of formula (A) with a guanidine reagent in a solvent system containing a halogenated alcohol advantageously and efficiently affords a compound of formula (B) in high yield. Without being bound to any particular theory, it is believed that the electron-withdrawing nature of the halo group in the halogenated alcohol solvent system favors the condensation reaction to produce the compound of formula (B) over the alternative reaction product.

[0023] Thus, in one aspect, there is provided herein a compound of formula (I): [ka] (In the formula, R 1a and R 1b , H, C 1~8 Alkyl, C 1~8 independently selected from the group consisting of alkoxy, and halogen; R 2a and R 2b is independently selected from the group consisting of H, CN, and halo; R 3 , H, C 1~8 selected from the group consisting of alkyl, and halogen; X is a leaving group selected from the group consisting of halogens and O-sulfonates. A method for preparing a) A compound of formula (A) [ka] (In the formula, R 4 is selected from the group consisting of C1-C8 alkyl and C3-C8 cycloalkyl, each of which is optionally substituted with 1-6 members independently selected from the group consisting of F and Cl. with a guanidine reagent and a solvent system containing at least one halogenated alcohol to produce a compound of formula (B) [ka] to obtain; and b) substituting the hydroxyl group of formula (B) to form a compound of formula (I); A method of preparation is disclosed, comprising:

[0024] In some embodiments of the above method, the compound of formula (I) is a compound of formula (Ia) [ka] It is.

[0025] In some embodiments in which a compound of formula (Ia) is prepared, step a) comprises: Compound of formula (Aa) [ka] with a guanidine reagent and a solvent system containing at least one halogenated alcohol to produce a compound of formula (Ba) [ka] (In the formula, R4 is as defined herein for formula B. This includes obtaining

[0026] The substituent R of the formula disclosed herein 1a , R 1b , R 2a , R 2b , and R 3 The phenyl ring having the substituent R 1a , R 1b , R 2a , R 2b , and R 3 A phenyl ring having R 1a is methyl. In some embodiments, R 2a is CN. In some embodiments, R 1b and R 2b are both H. In some embodiments, R 1a is methyl, R 2a is CN and R 1b , R 2b , and R 3 are H, respectively.

[0027] In some embodiments, R 4 is selected from the group consisting of methyl, ethyl, isopropyl, tert-butyl, and 2,2,2-trifluoroethyl. 4 is ethyl.

[0028] Regarding step a), the guanidine reagent is the core for preparing the desired product. There are many commercial sources of guanidine reagents that are useful in the present disclosure. In some embodiments, the guanidine reagent is selected from the group consisting of guanidine, guanidine HCl, guanidine carbonate, guanidine HBr, guanidine nitrate, guanidine HI, guanidine acetate, guanidine sulfate, guanidine hydrogen sulfate, guanidine thiocyanate, guanidine sulfamate, guanidine phosphate, and guanidine 4-benzenesulfonate. In some embodiments, the guanidine is guanidine carbonate. In some embodiments, the guanidine reagent is guanidine HCl.

[0029] As described above, the solvent system comprising at least one halogenated alcohol in step a) directs the reaction product in preference to the condensation product of formula (B). In some embodiments, the solvent system comprising at least one halogenated alcohol is selected from 2,2,2-trifluoroethanol, 2-fluoroethanol, and 2-chloroethanol. In some embodiments, the solvent system comprising at least one halogenated alcohol is only 2,2,2-trifluoroethanol. In some embodiments, the solvent system comprising at least one halogenated alcohol is a combination of 2,2,2-trifluoroethanol and an alcohol selected from the group consisting of methanol, ethanol, propanol, 2-fluoroethanol, 2-chloroethanol, 2-methoxyethanol, and 2-(methanesulfonyl)ethan-1-ol.

[0030] In some embodiments, the conversion in step a) further comprises a base. Suitable bases include NaH, NaOH, KOH, LiOH, Ca(OH), NaO-C 1~8 Alkyl, and KO-C 1~8 Examples of such alkyl groups include alkyl.

[0031] The conversion of step a) can be completed at a variety of different temperatures. Typically, step a) is heated to obtain a high level of desired conversion. In some embodiments, step a) is performed at reflux. In some embodiments, step a) is performed at a temperature above 70° C. In some embodiments, the conversion of step a) is performed at a temperature between about 75-105° C. In some embodiments, the conversion of step a) is performed at a temperature of about 100° C.

[0032] The reaction time of step a) will depend on many factors, such as the specific reagents used as well as the temperature. In some embodiments, the reaction of step a) is incubated for about 2, 4, 6, 8, 10, 12, 14, 16, or 18 hours or more. In some embodiments, the reaction of step a) is incubated for about 6 hours. In some embodiments, the reaction of step a) is incubated for about 14 hours.

[0033] The yield of the desired product for the conversion of step a) will vary depending on the exact reaction conditions employed. In some embodiments, the yield of Formula (B) in the conversion of step a) is greater than 60%. In some embodiments, the yield of Formula (B) in the conversion of step a) is at least 65%. In some embodiments, the yield of Formula (B) in the conversion of step a) is at least 70%. In some embodiments, the yield of Formula (B) in the conversion of step a) is at least 75%. In some embodiments, the yield of Formula (B) in the conversion of step a) is at least 80%.

[0034] The conversion described in step a) is often accompanied by the formation of small amounts of by-products. The small amounts of by-products formed are the products of the conversion of the compound of formula (A) to the compound of formula (i) [ka] This is a conversion to.

[0035] In some embodiments, the by-product form is a compound of formula (ia) [ka] It is.

[0036] In some embodiments, the methods described herein further comprise triturating the by-product of formula (i) or (ia) using an organic solvent. Organic solvents useful for triturating the undesired by-products include, but are not limited to, ethanol, methanol, acetonitrile, dichloromethane, ethyl acetate, and methyl tert-butyl ether (MTBE). In some embodiments, the organic solvent used is MTBE or dichloromethane.

[0037] Those skilled in the art will recognize that the amount of by-products formed will depend on the reaction conditions used. Typically, the amount of by-products formed will usually not exceed 20% of the total amount of Formula (A) converted from the starting material. In some embodiments, the amount of by-products formed will not exceed 15% of the total amount of Formula (A) converted from the starting material. In some embodiments, the amount of by-products formed will not exceed 10% of the total amount of Formula (A) converted from the starting material. In some embodiments, the amount of by-products formed will not exceed 5% of the total amount of Formula (A) converted from the starting material.

[0038] The modification or replacement of the hydroxyl group of formula (B) in step b) can be accomplished using a number of different reagents. In some embodiments, the hydroxyl is modified by a sulfonation process to give a compound of formula (I) where X is a sulfonic acid ester of the hydroxyl group. In some embodiments, step b) comprises a halogenation process where the hydroxyl of formula (B) is replaced with a halogen.

[0039] Sulfonation can be accomplished using sulfonating agents known in the art, including, but not limited to, methanesulfonyl chloride, trifluoromethanesulfonic anhydride, and 4-toluenesulfonyl chloride.

[0040] Halogenation can be accomplished using halogenating agents known in the art, including, but not limited to, POCl3, PSCl3, SOCl2, (COCl)2, PCl5, PBr3, N-chlorosuccinimide (NCS), and N-bromosuccinimide (NBS). In some embodiments, the halogenating agent is POCl3.

[0041] In some embodiments, the molar ratio of the halogenating or sulfonating agent to the compound of Formula (B) or Formula (Ba) is controlled. In some embodiments, the molar ratio of the halogenating or sulfonating agent to the compound of Formula (B) is about 1:1 to about 3:1, or about 1.2:1 to about 1.8:1.

[0042] Typically, the solvent system used in step b) is a polar aprotic organic solvent. Suitable polar aprotic organic solvents include, but are not limited to, acetonitrile, DMF, DMSO, NMP, and combinations thereof. In some embodiments, the polar aprotic organic solvent is acetonitrile.

[0043] In some embodiments, the conversion in step b) further comprises a base additive. Suitable base additives include trimethylamine, diisopropylethylamine, dimethylaniline, benzyltrimethylammonium chloride, and benzyltriethylammonium chloride. In some embodiments, the base additive is benzyltriethylammonium chloride.

[0044] The conversion of step b) can be completed at a variety of different temperatures. The preferred temperature will depend on the chemical conversion desired and the reagents used. One of skill in the art will be able to determine the appropriate temperature based on the reagents selected. In some embodiments, step b) is performed at an elevated temperature. In some embodiments, step b) is performed at a temperature of about 60-90° C. In some embodiments, step b) is performed at a temperature of about 67-83° C. In some embodiments, step b) is performed at a temperature of about 70° C. In some embodiments, step b) is performed at a temperature of about 80° C.

[0045] B. Preparation of Compounds of Formula (II) In some embodiments, a compound of formula (I) can be used in the preparation of a compound of formula (II). [ka] (In the formula, R 1a and R 1b , H, C 1~8 Alkyl, C 1~8 independently selected from the group consisting of alkoxy, and halogen; R 2a and R 2b is independently selected from the group consisting of H, CN, and halo; R 3 , H, C 1~8 alkyl, and halogen).

[0046] In such an embodiment, the method comprises: a') A compound of formula (A) [ka] (In the formula, R 4 is selected from the group consisting of C1-C8 alkyl and C3-C8 cycloalkyl, each of which may be optionally substituted with 1-6 elements. with a guanidine reagent to obtain a compound of formula (B), and then substituting the hydroxy group of formula (B) as described above to form a compound of formula (I); b') reacting the compound of formula (I) with a compound of formula (C) [ka] Converting into; and c') reacting the compound of formula (C) with an azide compound of formula (D) [ka] to form a compound of formula (II); Includes.

[0047] In some embodiments of the above-described methods, the compound of formula (II) is I Compound a) [ka] It is.

[0048] Formula (I I In the embodiment in which a compound of a) is prepared, a compound of formula (la) is prepared in step a'); step b') converts the compound of formula (la) into a compound of formula (Ca) [ka] step c) converting the compound of formula (Ca) into an azide compound of formula (D) to obtain a compound of formula (I I a) producing a compound of formula (1).

[0049] After the compound of formula (I) described herein is prepared, the X position of the compound of formula (I) is substituted with an acetylene group (step b') above). This can be done using any method known in the art, such as those described in WO2018 / 136700. In some embodiments, step b') comprises the following substeps: b'-l) contacting a compound of formula (I) with a silyl-protected acetylene together with a palladium catalyst and a copper cocatalyst to produce an intermediate of formula (C'): [ka] (In the formula, R 5 is a silyl protecting group); and b'-2) contacting the compound of formula (C') with a desilylation reagent to produce the compound of formula (C).

[0050] A variety of palladium and copper catalysts can be utilized in the described transformations. In some embodiments, the palladium catalyst is Pd(PPh3)2Cl2. In some embodiments, the copper co-catalyst is CuI.

[0051] The transformation in step b'-1) may also include a base. In some embodiments, the base is an amine base. A number of different amine bases are suitable for this transformation, including, but not limited to, triethylamine or N,N-diisopropylethylamine.

[0052] A number of different organic solvents can be used to carry out the conversion of step b'-1. Suitable organic solvents include tetrahydrofuran, acetonitrile, dichloromethane, ethyl acetate, and methyl tert-butyl ether (MTBE).

[0053] The conversion of step b'-1) can be carried out at a variety of different temperatures. In some embodiments, the conversion of step b'-1 is carried out at a temperature of about 20-90°C. In some embodiments, the conversion of step b'-1 is carried out at a temperature of about 30-75°C. In some embodiments, the conversion of step b'-1 is carried out at a temperature of about 40-60°C. In some embodiments, the conversion of step b'-1 is carried out at a temperature of about 50°C.

[0054] Typically, the conversion of step b'-1) is carried out over a period of several hours, although longer reaction times are contemplated. In some embodiments, the reaction is incubated for about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12 hours or more. In some embodiments, the reaction is incubated for about 3 hours. In some embodiments, the reaction is incubated for about 5 hours. In some embodiments, the reaction is incubated for about 7 hours.

[0055] The silyl-protected acetylene used in step b'-1) may include any number of silyl-protecting groups known in the art. Suitable groups include, but are not limited to, triisopropylsilyl, trimethylsilyl, thexyldimethylsilyl, benzyldimethylsilyl, biphenyldiisopropylsilyl, and tris(biphenyl-4-yl)silyl. In some embodiments, the silyl-protecting group is triisopropylsilyl.

[0056] The conversion of step b'-2) involves removing the silyl protecting group using a desilylation reagent. Many different methods and conditions for removing the silyl protecting group are known in the art and can be used in the methods disclosed herein. In some embodiments, the desilylation reagent used is selected from the group consisting of tetra-N-butylammonium fluoride (TBAF), tetrabutylammonium hydroxide, sodium tetrachloroaurate (III), and acetyl chloride. In one embodiment, step b'-2 includes tetrabutylammonium hydroxide (TBAH) (20 mol%) and a K2HPO4 buffer. In one embodiment, step b'-2 includes tetrabutylammonium hydroxide (20 mol%) and an acetate buffer.

[0057] Returning to step c') of the process for making the compound of formula II, this step uses click chemistry to couple the azide of formula (D) with the alkynyl group of formula (C) to form a tetrazole moiety. Click chemistry is a well-described and understood process, and one of ordinary skill in the art can readily identify suitable conditions for carrying out this reaction. In some embodiments, the reaction of step c') includes copper catalysis. A variety of copper catalysts can be used in this transformation, such as CuSO4, CuI, CuBr, copper(II) triflate, and copper(II) acetate. In some embodiments, the copper catalyst is CuSO4.

[0058] Azide compounds of formula (D) can be prepared, for example, as described in WO2018 / 136700.

[0059] C. Preparation of Compounds of Formula (A) In some embodiments, methods for preparing compounds having the formula (A) are also provided. [ka] (In the formula, R 1a and R 1b , H, C 1~8 Alkyl, C 1~8 independently selected from the group consisting of alkoxy, and halogen; R 2a and R 2b is independently selected from the group consisting of H, CN, and halo; R 3 , H, C 1~8 alkyl, and halogen).

[0060] Compounds of formula (A) can be prepared from known starting materials. For example, in some embodiments, compounds of formula (A) are i) A compound of formula (a) [ka] with a halogenating agent to prepare a compound of formula (b). [ka] (In the formula, Y is a halogen; R la and R lb , H, C 1~8 Alkyl, C 1~8 independently selected from the group consisting of alkoxy, and halogen; R 2a and R 2b is independently selected from the group consisting of H, CN, and halo; R 3 , H, C 1~8 selected from the group consisting of alkyl, and halogen; ii) reacting a compound of formula (b) with a compound of formula (c) in the presence of a base [ka] to form a compound of formula (A) [ka] (In the formula, R 4 is C 1~8 Alkyl and C 3~8 cycloalkyl, each of which is optionally substituted with 1 to 6 members independently selected from the group consisting of F and Cl.

[0061] Halogenation can be accomplished using halogenating agents known in the art, including, but not limited to, POCl3, PSCl3, SOCl2, (COCl)2, PCl5, PBr3, N-chlorosuccinimide (NCS), and N-bromosuccinimide (NBS). In some embodiments, the halogenating agent is (COCl)2.

[0062] Regarding step ii), the compound of formula (c) may also be provided in the form of a salt that also contains a cation. Suitable cations include, but are not limited to, K + , Na+ , and Li + Examples include:

[0063] In step ii), a number of bases can be used. Typically, an amine base is used. A number of different amine bases are suitable for this transformation, including but not limited to pyridine, triethylamine, or N,N-diisopropylethylamine.

[0064] In some embodiments, the converting in step ii) comprises a metal catalyst. In some embodiments, the metal catalyst is MgCl.

[0065] In some embodiments, the converting in step ii) comprises cooling the reaction to less than 20° C. before combining Formula (b) and Formula (c). In some embodiments, the converting in step ii) comprises cooling the reaction to less than 15° C. before combining Formula (b) and Formula (c). In some embodiments, the converting in step ii) comprises cooling the reaction to less than 10° C. before combining Formula (b) and Formula (c).

[0066] D. Preparation of Compounds of Formula (a') In some embodiments, methods for preparing compounds having formula (a') are also provided herein. [ka] (In the formula, R 1b , H, C 1~8 Alkyl, C 1~8 independently selected from the group consisting of alkoxy, and halogen; R 2b is independently selected from the group consisting of H, CN, and halo; R 3 , H, C 1~8 alkyl, and halogen).

[0067] Compounds of formula (a') may, in some embodiments, be of the formula: i) A compound of formula (a'y) [ka] with a cyanating reagent to obtain a compound of formula (a'x) [ka] (In the formula, R 1b , H, C 1~8 Alkyl, C 1~8 independently selected from the group consisting of alkoxy, and halogen; R 2b is independently selected from the group consisting of H, CN, and halo; R 3 , H, C 1~8 alkyl, and halogen) preparing a ii) contacting the compound of formula (a'y) with a Grignard reagent and CO2 to obtain a compound of formula (a'x); It can be prepared by

[0068] Cyanation can be carried out using cyanating agents known in the art, including but not limited to copper-mediated cyanating agents such as CuCN and KFe(CN). In one embodiment, cyanation is carried out using CuCN in the presence of NaNO and HCl.

[0069] Regarding step ii), the Grignard reagent is typically of the general formula R-Mg-X, where X is a halogen and R is an organic carbon group. Examples of Grignard reagents include, but are not limited to, methylmagnesium chloride, phenylmagnesium bromide, and isopropylmagnesium chloride. In one embodiment, step ii) is carried out using iPrMgCl in the presence of LiCl, THF, and CO2. EXAMPLES

[0070] Example 1: Trifluoroethanol-assisted condensation of β-ketoesters to give hydroxypyrimidines (and chloropyrimidines) [ka]

[0071] Step 1: 12M HCl at room temperature (aq) To a mixture of ethanol (26 mL) and water (26 mL) was added 3-bromo-2-methylaniline (18.6 g, 100 mmol) dropwise to form a fine white suspension. The mixture was cooled to 0° C. and a solution of sodium nitrite (7.31 g, 106 mmol) in water (15.1 mL) was added dropwise. The mixture was stirred at 0° C. for 30 minutes. To the resulting homogeneous mixture at 0° C. was added sodium bicarbonate (17.8 g, 212 mmol) at a rate to avoid excessive gas evolution. The aqueous phase of the resulting brown suspension was found to have a pH of about 7. The suspension was maintained at 0° C.

[0072] In a separate flask, copper cyanide (9.85 g, 110 mmol), potassium cyanide (13.0 g, 200 mmol), and water (31 mL) were heated to 60° C. to form a homogeneous solution. The above suspension was added dropwise to this solution at 60° C. with stirring to avoid excessive gas evolution. After addition, the mixture was stirred at 100° C. for 30 min. The mixture was cooled, MTBE (200 mL) was added, the mixture was stirred, filtered to remove solids, and washed with MTBE. The organic phase was dried over Na2SO4 and concentrated. The resulting crude product was purified by vacuum distillation to give the desired product as a pale orange solid (13.6 g, 69%).

[0073] Step 2: In a 2-L two-neck flask, the aryl bromide (101.9 g, 520 mmol, 1.0 equiv) was dissolved in THF (520 mL) under N2 atmosphere and the mixture was cooled in an ice-water bath. iPrMgCl·LiCl (400 mL, 1.3 M in THF, 520 mmol, 1.0 equiv) was added via cannula. After the addition was complete, the ice bath was removed. After 4 h, the flask was cooled in an ice-water bath and dry ice (approximately 230 g, 5.2 mol, 10 equiv) was added in portions to prevent overheating or boiling over (Note: CO2 gas can be bubbled into the solution instead of solid dry ice). After the addition was complete, the mixture was diluted with MTBE (500 mL) and 2 M HCl (250 mL). The layers were separated and the aqueous layer was washed with additional MTBE (500 mL). The organic layer was extracted with 10% NaOH (190 mL x 2) and the combined aqueous layers were cooled in an ice-water bath and acidified with concentrated HCl until a white precipitate formed. The precipitate was isolated by filtration, washed with water, and then dried overnight in a vacuum oven at 80°C to give the benzoic acid as a white solid (64.1 g, 76% yield).

[0074] Step 3: Benzoic acid (50 g, 311 mmol, 1.0 equiv) was suspended in CHCl and oxalyl chloride (40 mL, 466 mmol, 1.5 equiv) was added followed by DMF (ca. 30 drops). Immediate gas evolution was observed and the reaction flask was opened to the atmosphere under a positive pressure of N. After complete consumption of the starting acid as determined by LCMS and visual inspection (complete dissolution of starting material), the reaction mixture was concentrated. Excess oxalyl chloride was removed by azeotropic distillation with toluene to give the corresponding acid chloride as a brown solid.

[0075] In a separate two-neck flask equipped with an overhead stirrer, potassium ethyl malonate (66.1 g, 388 mmol, 1.25 equiv), triethylamine (108 mL, 777 mmol, 2.5 equiv), and MeCN (777 mL) were cooled in a salt / ice-salt bath. Solid MgCl2 (74 g, 777 mmol, 2.5 equiv) was added and the resulting suspension was stirred vigorously at approximately -10 °C. After 1 h, the solid acid chloride was added at a rate that ensured dissolution in a thick suspension. The suspension quickly became homogeneous and the stirring rate was reduced to avoid splashing. The ice bath was removed. After complete consumption of starting material as determined by TLC analysis, the reaction mixture was cooled in an ice-water bath and 2 M HCl (971 mL, 1.9 mol, 6.25 equiv) was added and the ice bath was removed. After 30 min, the layers were separated and the aqueous layer was extracted with MTBE. The combined organic layers were washed with saturated NaHCO.sub.3 and brine, dried over sodium sulfate, filtered, and concentrated to give the ketoester as a brown solid (67 g, 93% yield).

[0076] Step 4: A round-bottom flask was charged with 42.0 g (181.8 mmol) of the β-ketoester, 32.7 g (181.8 mmol) of guanidine carbonate, and 227 mL of trifluoroethanol. The suspension was then heated to reflux under N for 16 h.

[0077] Workup: The reaction was cooled to room temperature and the solvent was evaporated under reduced pressure to give a viscous red oil. The oil was redissolved in 250 mL of HO and the aqueous solution was extracted with dichloromethane (2×250 mL). The aqueous phase was then washed with 1.0 M HCl. (aq) Acidify to pH approx. 2-3 using 1,2-dichloromethane. The precipitated product was collected by filtration, washed thoroughly with HO, and dried in a vacuum oven at 70° C. Yield 30.81 g (75%), purity >99%.

[0078] Step 5: A round-bottom flask was charged with 50.0 g (221.2 mmol) of pyrimidone from step 4 and 100.8 g (442.2 mmol) of benzyltriethylammonium chloride. The mixture was suspended in 442.2 mL of dry acetonitrile and 31.0 mL (331.8 mmol) of POCl3 was added. The suspension thus obtained was then heated to reflux under N2 for 4 h.

[0079] Workup: The reaction was cooled to room temperature and about 200 g of crushed ice was added. The mixture was then stirred for 30 min, then ice-cold 15% aqueous NH4OH was added dropwise to about pH 10-11 (Note: It is recommended to add cold NH4OH slowly to avoid a sudden exotherm due to quenching of excess POCI3). The suspension was then stirred at room temperature for another 1.5 h. The precipitated product was collected by filtration, washed thoroughly with H2O, and dried in a vacuum oven at 70 °C. Yield 48.2 g (89%), purity >99%.

[0080] HPLC conditions HPLC: Agilent 1100 Column: YMC-HPLC column; 250×4.6; S-5μm, 20nm; AQ20S05-2546WT; No. 0425058945 Solvent: H2O / MeCN containing 0.1% HCO2H Flow rate: 0.8mL / min Column temperature: 30℃ method: [ka]

[0081] Example 2: Comparative pyrimidine coupling Shown below is a synthetic route for preparing 3-[2-amino-6-(1-{[6-(2-hydroxypropan-2-yl)pyridin-2-yl]methyl}-1H-1,2,3-triazol-4-yl)pyrimidin-4-yl]-2-methylbenzonitrile, which utilizes a boronic ester benzonitrile to link the phenyl and pyrimidine rings, and is also shown in WO2018 / 136700. [ka]

[0082] The following scheme illustrates the synthetic route used to prepare the boronic ester benzonitriles used in the above process and subsequent reaction with pyrimidines to form compounds of formula (I). In particular, the desired linkage between the pyrimidine and phenyl gives less than 50% yield. [ka]

[0083] The following scheme illustrates the synthetic route used to prepare compounds of formula (I) utilizing the conversion of a β-diketoester to a pyrimidine using guanidine, which gives a 75% yield. [ka]

[0084] Certain embodiments of the invention are described herein, including the best mode known to the inventors for carrying out the invention. It is expected that, upon reading the foregoing description, variations of the disclosed embodiments may become apparent to those working in the art, who may then adopt such variations as necessary. Accordingly, it is intended that the invention be practiced otherwise than as specifically described herein, and that the invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or clearly contradicted by context.

[0085] All publications, patent applications, accession numbers, and other references cited herein are incorporated by reference in their entirety. The references are provided unless specifically and individually indicated to be incorporated by reference. No. 6,399,413, which are incorporated herein by reference as if fully set forth herein. The present invention provides, for example, the following items. (Item 1) Compounds represented by formula (I): [ka] (In the formula, R 1a and R 1b , H, C 1~8 Alkyl, C 1~8 alkoxy, and halogen; independently selected; R 2a and R 2b is independently selected from the group consisting of H, CN, and halo; R 3 , H, C 1~8 selected from the group consisting of alkyl, and halogen; X is a leaving group selected from the group consisting of halogens and O-sulfonates. A method for preparing a) A compound of formula (A)

change

change

change

change

change

change

change

change

change

change

change

change

change

change

change

change

change

change

change

Claims

1. Compounds represented by formula (I): 【Chemistry 1】 (In the formula, R 1a and R 1b is H and C 1~8 independently selected from the group consisting of alkyl; R 2a and R 2b is independently selected from the group consisting of H and CN; R 3 is H; X is a halogen. A method for preparing a) a compound of formula (A) 【Chemistry 2】 (In the formula, R 4 is C 1 ~C 8 Alkyl and C 3 ~C 8 cycloalkyl each of which is optionally substituted with 1 to 6 members independently selected from the group consisting of F and Cl. with a guanidine reagent and a solvent system containing at least one halogenated alcohol to produce a compound of formula (B) 【Chemistry 3】 to obtain; and b) substituting the hydroxyl group of formula (B) to form a compound of formula (I); The preparation method comprising:

2. 2. The process according to claim 1, wherein step b) is a halogenation process to give a compound of formula (I) where X is a halogen.

3. The halogenation process comprises adding POCl 3 , PSC 3 , SOCl 2 , (COCl) 2 , PCl 5 , PBr 3 3. The method of claim 2, wherein a halogenating agent selected from the group consisting of N-chlorosuccinimide (NCS) and N-bromosuccinimide (NBS) is used.

4. 2. The method of claim 1, wherein the guanidine reagent is selected from the group consisting of guanidine, guanidine HCl, guanidine carbonate, guanidine HBr, guanidine nitrate, guanidine HI, guanidine acetate, guanidine sulfate, guanidine hydrogen sulfate, guanidine thiocyanate, guanidine sulfamate, guanidine phosphate, and guanidine 4-benzenesulfonate.

5. R 4 are methyl, ethyl, isopropyl, tert-butyl, and 2,2,2-triphenyl 2. The method of claim 1, wherein the compound is selected from the group consisting of fluoroethyl.

6. R 4 The method of claim 1 , wherein is ethyl.

7. 2. The method of claim 1, wherein the guanidine reagent is selected from the group consisting of guanidine HCl and guanidine carbonate.

8. 2. The method of claim 1, wherein the solvent system comprising at least one halogenated alcohol is a combination of 2,2,2-trifluoroethanol and an alcohol selected from the group consisting of methanol, ethanol, propanol, 2-fluoroethanol, 2-chloroethanol, 2-methoxyethanol, and 2-(methanesulfonyl)ethan-1-ol.

9. 2. The method of claim 1, wherein the solvent system comprising at least one halogenated alcohol is exclusively 2,2,2-trifluoroethanol.

10. 2. The method of claim 1, wherein step b) is carried out in a polar aprotic organic solvent.

11. 11. The method of claim 10, wherein the polar aprotic organic solvent is selected from the group consisting of acetonitrile, DMF, DMSO, NMP, and combinations thereof.

12. Step b) is the addition of POCl to give a compound of formula (I) where X is Cl. 3 Use 11. The method of claim 10, wherein the halogenation process is carried out by reacting 1,2,3,4-trimethylphenyl ether with 1,2,4-trimethylphenyl ether, wherein the guanidine reagent in step a) is guanidine carbonate and the polar aprotic organic solvent is acetonitrile.

13. The process according to any one of claims 1 to 12, wherein step b) is carried out at a temperature of from 67 to 83°C.

14. 2. The method of claim 1, wherein the solvent system comprising the compound of formula (A), the guanidine reagent, and 2,2,2-trifluoroethanol is heated to reflux temperature.

15. Prior to step b), a by-product of formula (i) 【Chemistry 4】 2. The method of claim 1, wherein the compound of formula (B) is triturated with an organic solvent to remove

16. 16. The method of claim 15, wherein the organic solvent is selected from the group consisting of ethanol, methanol, acetonitrile, dichloromethane, ethyl acetate, and methyl tert-butyl ether.

17. The method of claim 10, wherein step b) is carried out with a base additive.

18. 18. The method of claim 17, wherein the base additive is selected from the group consisting of trimethylamine, diisopropylethylamine, dimethylaniline, benzyltrimethylammonium chloride, and benzyltriethylammonium chloride.

19. 18. The method of claim 17, wherein the base additive is benzyltriethylammonium chloride.

20. The compound of formula (A) i) A compound of formula (a) 【Chemistry 5】 with a halogenating agent to prepare a compound of formula (b). 【Chemistry 6】 (In the formula, Y is a halogen; R la and R lb is H and C 1~8 independently selected from the group consisting of alkyl; R 2a and R 2b is independently selected from the group consisting of H and CN; R 3 is H); ii) reacting the compound of formula (b) with a compound of formula (c) in the presence of a base 【Chemistry 7】 to form a compound of formula (A) 【Chemistry 8】 (In the formula, R 4 is C 1~8 Alkyl and C 3~8 cycloalkyl, each of which is optionally substituted with 1 to 6 members independently selected from the group consisting of F and Cl; The method of claim 1 , wherein the compound is prepared by

21. 21. The method of claim 20, wherein the compound of formula (a) is a compound of formula (a'): 【Chemistry 9】 (In the formula, R 1b is H; R 2b is H; R 3 is H).

22. Compound of formula (II): 【Chemistry 12】 (In the formula, R 1a and R 1b is H and C 1~8 independently selected from the group consisting of alkyl; R 2a and R 2b is independently selected from the group consisting of H and CN; R 3 is H) A method for preparing a') preparing a compound of formula (I) according to a method according to any one of claims 1 to 21; b') reacting the compound of formula (I) with a compound of formula (C) 【Chemistry 13】 converting it into c') reacting the compound of formula (C) with an azide compound of formula (D) 【Chemistry 14】 to form the compound of formula (II); The preparation method comprising:

23. Step b') Step b'-l) contacting the compound of formula (I) with a silyl-protected acetylene, a palladium catalyst and a copper cocatalyst to produce an intermediate of formula (C'): 【Chemistry 15】 (In the formula, R 5 is a silyl protecting group; and Step b'-2) contacting the compound of formula (C') with a desilylation reagent to produce the compound of formula (C); 23. The method of claim 22, comprising:

24. 24. The method of claim 23, wherein the silyl protecting group is selected from the group consisting of triisopropylsilyl, trimethylsilyl, thexyldimethylsilyl, benzyldimethylsilyl, biphenyldiisopropylsilyl, and tris(biphenyl-4-yl)silyl.

25. The palladium catalyst is Pd(PPh 3 ) 2 C 2 and the copper promoter is CuI; 24. The method of claim 23.

26. The method of any one of claims 23 to 25, wherein step b'-1) uses an amine base.

27. 27. The method of claim 26, wherein the amine base is triethylamine or N,N-diisopropylethylamine.

28. 28. The method of any one of claims 23 to 27, wherein the desilylation reagent is selected from the group consisting of tetrabutylammonium fluoride (TBAF), tetrabutylammonium hydroxide, sodium tetrachloroaurate (III), and acetyl chloride.

29. The method of any one of claims 22 to 28, wherein step c') further comprises a copper catalyst.

30. The copper catalyst is CuSO 4 , CuI, CuBr, copper(II) triflate, and copper acetate 30. The method of claim 29, wherein the compound is selected from the group consisting of: (II).

31. Compound of formula (IIa) 【Chemistry 16】 A method for preparing a') obtaining a compound of formula (Ia) according to the method of any one of claims 1 to 19 【Chemistry 17】 preparing b') reacting the compound of formula (Ia) with a compound of formula (Ca) 【Chemistry 18】 converting it into c') reacting the compound of formula (Ca) with an azide compound of formula (D) 【Chemistry 19】 to form the compound of formula (IIa); The preparation method comprising:

32. Step b') b'-l) contacting the compound of formula (Ia) with triisopropylsilylacetylene to produce an intermediate of formula (Ca'): 【Chemistry 20】 and b'-2) contacting the compound of formula (Ca') with a desilylation reagent to produce the compound of formula (Ca); 32. The method of claim 31 , comprising:

33. 33. The method of claim 32, wherein the contacting of the compound of formula (Ia) with triisopropylsilylacetylene utilizes a palladium catalyst and a copper cocatalyst.

34. The palladium catalyst is Pd(PPh 3 ) 2 C 2 or Pd(OAc) 2 34. The method of claim 33, wherein the copper promoter is CuI.

35. The method of any one of claims 32 to 34, further comprising utilizing an amine base in contacting the compound of formula (Ia) with triisopropylsilylacetylene.

36. 36. The method of claim 35, wherein the amine base is triethylamine or N,N-diisopropylethylamine.

37. 37. The method of any one of claims 32 to 36, wherein the desilylation reagent is selected from the group consisting of tetrabutylammonium fluoride (TBAF), tetrabutylammonium hydroxide (TBAH), sodium tetrachloroaurate (III), and acetyl chloride.

38. 32. The method of claim 31 , wherein step c′) further comprises a copper catalyst.

39. The copper catalyst is CuSO 4 40. The method of claim 38, wherein the copper(II) salt is selected from the group consisting of CuI, CuBr, copper(II) triflate, and copper(II) acetate.

Citation Information

Patent Citations

  • Azolopyrimidine for the treatment of cancer-related disorders

    WO2018136700A1